SGLT2 Inhibitor Use Not Tied to Increased Fracture Risk in CKD
Compared with DPP-4 inhibitor use, SGLT2 inhibitor use not associated with higher risk for fractures, regardless of eGFR
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.